Drug Dispensing Device

DE602021056853T2Active Publication Date: 2026-07-08MASSACHUSETTS INST OF TECH +2

View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: DE · DE
Patent Type: Patents
Current Assignee / Owner: MASSACHUSETTS INST OF TECH
Filing Date: 2021-08-09
Publication Date: 2026-07-08

AI Technical Summary

Technical Problem

Certain therapeutics composed of large and complex molecules denature when administered via the oral-gastrointestinal route, necessitating more invasive forms of drug administration like subcutaneous injection, which can lead to adherence issues and reduced quality of life.

Method used

An ingestible drug delivery device using needleless micro-jets to deliver active pharmaceutical ingredients at specific locations within the gastrointestinal tract, employing a rupturable membrane and a potential energy source to release a controlled micro-jet of the API, with a trigger mechanism that activates based on predetermined conditions.

Benefits of technology

Facilitates non-invasive delivery of large and complex molecules, reducing pain and trauma, enhancing pharmacokinetics, and ensuring consistent API delivery to the GI mucosal lining.

✦ Generated by Eureka AI based on patent content.

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.